Cobalt chloride enhances angiogenic potential of CD133+ cells

Frontiers in Bioscience

Volumn 17, Issue 6, 2011, Pages 2247-2258

  Zan, Tao ^a   Du, Zijing ^a   Li, Hua ^a   Li, Qing Feng ^a   Gu, Bin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cobalt Chloride; Hypoxia; SDF 1; Umbilical cord blood

Indexed keywords

CD133 ANTIGEN; COBALT; COBALT CHLORIDE; CXCL12 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR; GLYCOPROTEIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEUKOCYTE ANTIGEN; MESSENGER RNA; PEPTIDE; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CELL HYPOXIA; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; FETUS BLOOD; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; STEM CELL;

ANTIGENS, CD; CELL HYPOXIA; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; COBALT; ENDOTHELIAL CELLS; FETAL BLOOD; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES; RNA, MESSENGER; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84860267085     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4048     Document Type: Article

References (61)

1. M. N. Sabri, G. DiSciascio, M. J. Cowley, D. Alpert and G. W. Vetrovec: Coronary collateral recruitment: functional significance and relation to rate of vessel closure. Am Heart J, 121 (3 Pt 1), 876-80 (1991)
2. R. H. Helfant, P. S. Vokonas and R. Gorlin: Functional importance of the human coronary collateral circulation. N Engl J Med, 284 (23), 1277-81 (1971)
3. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman and J. M. Isner: Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275 (5302), 964-7 (1997) (Pubitemid 27087709)
4. D. W. Losordo and S. Dimmeler: Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation, 109 (22), 2692-7 (2004) (Pubitemid 38737912)
5. M. Hofmann, K. C. Wollert, G. P. Meyer, A. Menke, L. Arseniev, B. Hertenstein, A. Ganser, W. H. Knapp and H. Drexler: Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation, 111 (17), 2198-202 (2005) doi:01.CIR.0000163546.27639.AA (Pubitemid 40632435)
6. S. Dimmeler, A. M. Zeiher and M. D. Schneider: Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest, 115 (3), 572-83 (2005) doi:10.1172/JCI24283 (Pubitemid 40322227)
7. D. J. Ceradini, A. R. Kulkarni, M. J. Callaghan, O. M. Tepper, N. Bastidas, M. E. Kleinman, J. M. Capla, R. D. Galiano, J. P. Levine and G. C. Gurtner: Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med, 10 (8), 858-64 (2004) (Pubitemid 39070860)
8. J. D. Abbott, Y. Huang, D. Liu, R. Hickey, D. S. Krause and F. J. Giordano: Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation, 110 (21), 3300-5 (2004) (Pubitemid 39557491)
9. G. Zhang, Y. Nakamura, X. Wang, Q. Hu, L. J. Suggs and J. Zhang: Controlled release of stromal cellderived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng, 13 (8), 2063-71 (2007) (Pubitemid 47294002)
10. W. G. An, M. Kanekal, M. C. Simon, E. Maltepe, M. V. Blagosklonny and L. M. Neckers: Stabilization of wildtype p53 by hypoxia-inducible factor 1alpha. Nature, 392 (6674), 405-8 (1998)
11. M. C. Yoder, L. E. Mead, D. Prater, T. R. Krier, K. N. Mroueh, F. Li, R. Krasich, C. J. Temm, J. T. Prchal and D. A. Ingram: Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood, 109 (5), 1801-9 (2007) (Pubitemid 46348173)
12. S. Miraglia, W. Godfrey, A. H. Yin, K. Atkins, R. Warnke, J. T. Holden, R. A. Bray, E. K. Waller and D. W. Buck: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood, 90 (12), 5013-21 (1997) (Pubitemid 28007218)
13. A. H. Yin, S. Miraglia, E. D. Zanjani, G. Almeida-Porada, M. Ogawa, A. G. Leary, J. Olweus, J. Kearney and D. W. Buck: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90 (12), 5002-12 (1997) (Pubitemid 28007217)
14. M. Peichev, A. J. Naiyer, D. Pereira, Z. Zhu, W. J. Lane, M. Williams, M. C. Oz, D. J. Hicklin, L. Witte, M. A. Moore and S. Rafii: Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood, 95 (3), 952-8 (2000) (Pubitemid 30062717)
15. M. Reyes, A. Dudek, B. Jahagirdar, L. Koodie, P. H. Marker and C. M. Verfaillie: Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest, 109 (3), 337-46 (2002) (Pubitemid 34141807)
16. E. J. Suuronen, J. P. Veinot, S. Wong, V. Kapila, J. Price, M. Griffith, T. G. Mesana and M. Ruel: Tissueengineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation, 114 (1 Suppl), I138-44 (2006) (Pubitemid 44297142)
17. C. Stamm, H. D. Kleine, Y. H. Choi, S. Dunkelmann, J. A. Lauffs, B. Lorenzen, A. David, A. Liebold, C. Nienaber, D. Zurakowski, M. Freund and G. Steinhoff: Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg, 133 (3), 717-25 (2007)
18. R. Kolvenbach, C. Kreissig, E. Ludwig and C. Cagiannos: Stem cell use in critical limb ischemia. J Cardiovasc Surg (Torino), 48 (1), 39-44 (2007) (Pubitemid 46416562)
19. S. Loges, B. Fehse, M. A. Brockmann, K. Lamszus, M. Butzal, M. Guckenbiehl, G. Schuch, S. Ergun, U. Fischer, A. R. Zander, D. K. Hossfeld, W. Fiedler and U. M. Gehling: Identification of the adult human hemangioblast. Stem Cells Dev, 13 (3), 229-42 (2004) (Pubitemid 38738365)
20. H. M. DeLisser, M. Christofidou-Solomidou, R. M. Strieter, M. D. Burdick, C. S. Robinson, R. S. Wexler, J. S. Kerr, C. Garlanda, J. R. Merwin, J. A. Madri and S. M. Albelda: Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol, 151 (3), 671-7 (1997) (Pubitemid 27385598)
21. C. Garlanda and E. Dejana: Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol, 17 (7), 1193-202 (1997) (Pubitemid 27329839)
22. A. Kawamoto, H. C. Gwon, H. Iwaguro, J. I. Yamaguchi, S. Uchida, H. Masuda, M. Silver, H. Ma, M. Kearney, J. M. Isner and T. Asahara: Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation, 103 (5), 634-7 (2001) (Pubitemid 32144189)
23. R. H. Wenger: Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J, 16 (10), 1151-62 (2002) (Pubitemid 34815403)
24. C. W. Pugh and P. J. Ratcliffe: Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med, 9 (6), 677-84 (2003) (Pubitemid 36749216)
25. G. L. Semenza and G. L. Wang: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol, 12 (12), 5447-54 (1992)
26. E. Laughner, P. Taghavi, K. Chiles, P. C. Mahon and G. L. Semenza: HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol, 21 (12), 3995-4004 (2001) (Pubitemid 32476461)
27. G. L. Wang and G. L. Semenza: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A, 90 (9), 4304-8 (1993) (Pubitemid 23134215)
28. G. L. Wang, B. H. Jiang, E. A. Rue and G. L. Semenza: Hypoxia-inducible factor 1 is a basic-helix-loophelix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A, 92 (12), 5510-4 (1995)
29. M. Simons and J. A. Ware: Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov, 2 (11), 863-71 (2003) (Pubitemid 37407792)
30. M. Yamakawa, L. X. Liu, T. Date, A. J. Belanger, K. A. Vincent, G. Y. Akita, T. Kuriyama, S. H. Cheng, R. J. Gregory and C. Jiang: Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res, 93 (7), 664-73 (2003) (Pubitemid 37222163)
31. H. J. Knowles, Y. M. Tian, D. R. Mole and A. L. Harris: Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases. Circ Res, 95 (2), 162-9 (2004) (Pubitemid 38988682)
32. M. Jiang, B. Wang, C. Wang, B. He, H. Fan, T. B. Guo, Q. Shao, L. Gao and Y. Liu: Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs. J Cell Biochem, 103 (1), 321-34 (2008)
33. D. A. Elson, G. Thurston, L. E. Huang, D. G. Ginzinger, D. M. McDonald, R. S. Johnson and J. M. Arbeit: Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxiainducible factor-1alpha. Genes Dev, 15 (19), 2520-32 (2001) (Pubitemid 32937863)
34. M. Jiang, B. Wang, C. Wang, B. He, H. Fan, Q. Shao, L. Gao, Y. Liu, G. Yan and J. Pu: In vivo enhancement of angiogenesis by adenoviral transfer of HIF-1alpha-modified endothelial progenitor cells (Ad-HIF-1alpha-modified EPC for angiogenesis). Int J Biochem Cell Biol, 40 (10), 2284-95 (2008)
35. J. Li, M. Post, R. Volk, Y. Gao, M. Li, C. Metais, K. Sato, J. Tsai, W. Aird, R. D. Rosenberg, T. G. Hampton, F. Sellke, P. Carmeliet and M. Simons: PR39, a peptide regulator of angiogenesis. Nat Med, 6 (1), 49-55 (2000) (Pubitemid 30048525)
36. J. K. Maranchie, J. R. Vasselli, J. Riss, J. S. Bonifacino, W. M. Linehan and R. D. Klausner: The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell, 1 (3), 247-55 (2002) (Pubitemid 41039149)
37. M. Ivan, T. Haberberger, D. C. Gervasi, K. S. Michelson, V. Gunzler, K. Kondo, H. Yang, I. Sorokina, R. C. Conaway, J. W. Conaway and W. G. Kaelin, Jr.: Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxiainducible factor. Proc Natl Acad Sci U S A, 99 (21), 13459-64 (2002) (Pubitemid 35215403)
38. M. Bosch-Marce, H. Okuyama, J. B. Wesley, K. Sarkar, H. Kimura, Y. V. Liu, H. Zhang, M. Strazza, S. Rey, L. Savino, Y. F. Zhou, K. R. McDonald, Y. Na, S. Vandiver, A. Rabi, Y. Shaked, R. Kerbel, T. Lavallee and G. L. Semenza: Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res, 101 (12), 1310-8 (2007) (Pubitemid 350294648)
39. K. A. Mace, D. H. Yu, K. Z. Paydar, N. Boudreau and D. M. Young: Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair. Wound Repair Regen, 15 (5), 636-45 (2007) (Pubitemid 47493890)
40. H. Iwaguro, J. Yamaguchi, C. Kalka, S. Murasawa, H. Masuda, S. Hayashi, M. Silver, T. Li, J. M. Isner and T. Asahara: Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation, 105 (6), 732-8 (2002) (Pubitemid 34157378)
41. N. Ferrari, J. Glod, J. Lee, D. Kobiler and H. A. Fine: Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors. Gene Ther, 10 (8), 647-56 (2003) (Pubitemid 36553610)
42. J. Yamaguchi, K. F. Kusano, O. Masuo, A. Kawamoto, M. Silver, S. Murasawa, M. Bosch-Marce, H. Masuda, D. W. Losordo, J. M. Isner and T. Asahara: Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation, 107 (9), 1322-8 (2003) (Pubitemid 36314418)
43. O. Salvucci, L. Yao, S. Villalba, A. Sajewicz, S. Pittaluga and G. Tosato: Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood, 99 (8), 2703-11 (2002) (Pubitemid 34525355)
44. I. Kryczek, A. Lange, P. Mottram, X. Alvarez, P. Cheng, M. Hogan, L. Moons, S. Wei, L. Zou, V. Machelon, D. Emilie, M. Terrassa, A. Lackner, T. J. Curiel, P. Carmeliet and W. Zou: CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res, 65 (2), 465-72 (2005)
45. A. N. Carr, B. W. Howard, H. T. Yang, E. Eby-Wilkens, P. Loos, A. Varbanov, A. Qu, J. P. DeMuth, M. G. Davis, A. Proia, R. L. Terjung and K. G. Peters: Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endotheliumdependent mechanism. Cardiovasc Res, 69 (4), 925-35 (2006) (Pubitemid 43227991)
46. T. Akita, T. Murohara, H. Ikeda, K. Sasaki, T. Shimada, K. Egami and T. Imaizumi: Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest, 83 (1), 65-73 (2003) (Pubitemid 36126051)
47. M. P. Simon, R. Tournaire and J. Pouyssegur: The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. J Cell Physiol, 217 (3), 809-18 (2008)
48. J. A. Forsythe, B. H. Jiang, N. V. Iyer, F. Agani, S. W. Leung, R. D. Koos and G. L. Semenza: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol, 16 (9), 4604-13 (1996) (Pubitemid 26272112)
49. B. D. Kelly, S. F. Hackett, K. Hirota, Y. Oshima, Z. Cai, S. Berg-Dixon, A. Rowan, Z. Yan, P. A. Campochiaro and G. L. Semenza: Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res, 93 (11), 1074-81 (2003) (Pubitemid 37485038)
50. T. Nagasawa, H. Kikutani and T. Kishimoto: Molecular cloning and structure of a pre-B-cell growthstimulating factor. Proc Natl Acad Sci U S A, 91 (6), 2305-9 (1994) (Pubitemid 24092092)
51. I. Petit, M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, L. Habler, T. Ponomaryov, R. S. Taichman, F. Arenzana-Seisdedos, N. Fujii, J. Sandbank, D. Zipori and T. Lapidot: G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol, 3 (7), 687-94 (2002) (Pubitemid 34752479)
52. M. Kucia, K. Jankowski, R. Reca, M. Wysoczynski, L. Bandura, D. J. Allendorf, J. Zhang, J. Ratajczak and M. Z. Ratajczak: CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol, 35 (3), 233-45 (2004) (Pubitemid 40585309)
53. A. M. Byrne, D. J. Bouchier-Hayes and J. H. Harmey: Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med, 9 (4), 777-94 (2005) (Pubitemid 43116546)
54. M. Hristov and C. Weber: Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med, 8 (4), 498-508 (2004) (Pubitemid 44145482)
55. C. Urbich and S. Dimmeler: Endothelial progenitor cells: characterization and role in vascular biology. Circ Res, 95 (4), 343-53 (2004) (Pubitemid 39100452)
56. S. Dimmeler, A. Aicher, M. Vasa, C. Mildner-Rihm, K. Adler, M. Tiemann, H. Rutten, S. Fichtlscherer, H. Martin and A. M. Zeiher: HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest, 108 (3), 391-7 (2001) (Pubitemid 32730785)
57. C. Kalka, H. Masuda, T. Takahashi, W. M. Kalka-Moll, M. Silver, M. Kearney, T. Li, J. M. Isner and T. Asahara: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A, 97 (7), 3422-7 (2000) (Pubitemid 30183318)
58. K. Hattori, B. Heissig, K. Tashiro, T. Honjo, M. Tateno, J. H. Shieh, N. R. Hackett, M. S. Quitoriano, R. G. Crystal, S. Rafii and M. A. Moore: Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood, 97 (11), 3354-60 (2001)
59. Y. Zhang, Y. Adachi, Y. Suzuki, K. Minamino, M. Iwasaki, K. Nakano, Y. Koike, H. Mukaide, A. Shigematsu, N. Kiriyama, C. Li and S. Ikehara: Synergistic effects of granulocyte-colony stimulating factor and macrophage-colony stimulating factor on recovery of donor hematopoietic cells in allogeneic bone marrow transplantation. Oncol Rep, 16 (2), 367-71 (2006)
60. D. J. Manalo, A. Rowan, T. Lavoie, L. Natarajan, B. D. Kelly, S. Q. Ye, J. G. Garcia and G. L. Semenza: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood, 105 (2), 659-69 (2005) (Pubitemid 40070750)
61. R. Salcedo, K. Wasserman, H. A. Young, M. C. Grimm, O. M. Howard, M. R. Anver, H. K. Kleinman, W. J. Murphy and J. J. Oppenheim: Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol, 154 (4), 1125-35 (1999) (Pubitemid 29169747)